Providence distributed this information during the week of June 5, 2023
The below information is intended to inform you about shortages with certain chemotherapy agents and other oncology-related medications.
Why are we raising this concern?
• There is a critical shortage of about 300 drugs affecting hospitals and care facilities across the U.S. right now, including Providence St. Patrick Hospital and Providence St. Joseph Medical Center.
• Chemotherapy and oncology-related medications are especially impaed by these shortages.
• Medications such as Carboplatin, Cisplatin, Fluorouracil, Capecitabine, Abiraterone, Docetaxel, Doxorubicin, Fludarabine, Methotrexate, Vincristine, and many others have been or may become affected.
How are we responding to these medication shortages?
• Providing you with safe, high-quality care is our top priority. Making you aware of this issue is important as we work with you and the rest of the care team on possible alternatives.
• Providence Montana and our partners are exploring strategies to secure additional supply of these medications. We are also engaged in advocacy efforts to find long-term solutions and prevent recurrences in the future.
• Treatment plans may be modified after careful review by the care team and discussion with you. These modifications will be individualized to you and will only be made if it is clinically appropriate and safe to do so.
• We are committed to the fair and equitable treatment of all our patients. Only medical factors such as disease type, stage, and prior treatment are being considered in the selection of which patient’s regimen may be impacted.
• Options for modifications in the treatment plan may include a decrease from the usual dosage or substitution of an alternative agent, when possible.
• Our care team will reach out to you if your treatment plan may need to be modified.
• We will be with you every step of the way and will work to ensure you continue to receive the best care.
No comments:
Post a Comment